# Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry

> **NCT02851745** · PHASE3 · COMPLETED · sponsor: **Heart Care Foundation** · enrollment: 188 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Left Ventricular Systolic Dysfunction

## Interventions

- **DRUG:** Linagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02851745
- **Lead sponsor:** Heart Care Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2019-07-02
- **Final completion:** 2019-07-02
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2021-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02851745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02851745, "Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02851745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*